Mission & Vision
We are board certified Oncologists pioneering a new medical subspecialty—PreOncology—focused on detecting and preventing cancer at its earliest, most curable stage. We empower patients and providers with personalized risk scores, AI-driven insights, and cutting-edge diagnostics that shift cancer care from late-stage reaction to proactive prevention.
​
​We envision a future where cancer is prevented or intercepted before it becomes visible or symptomatic. A Multi-Omics platform that integrates AI, genetics, liquid biopsy, and whole-body MRI into a unified platform, we aim to make Stage Alpha detection a standard part of health care—giving people more time, more options, and more peace of mind.
Our Company
PreOncology is backed by Oncoled Ventures, a physician-led venture fund supported by U.S. oncologists. This foundation ensures that our work is both scientifically rigorous and deeply connected to the realities of cancer care.
1. Mission Alignment – Our work is physician-driven, with the potential to translate quickly to meaningful patient outcomes.
2. Clinical Relevance –We have strong ties to the real-world cancer community.
3. Financial Responsibility – We have the resources to support patient-centered long-term projects.
Meet the Team
Meet the core team pioneering PreOncology—a group of innovators, clinicians, and design leaders committed to redefining cancer care through ultra-early detection and prevention.
